Δευτέρα 10 Απριλίου 2017

Treatment choices for HER2 amplified colorectal cancer

Dr Marsoni speaks with ecancer at AACR 2017 about the use of patient-derived xenografts of colorectal cancer to identify the role of HER2 amplification in cetuximab-resistant tumour types. She describes how a combination of lapatanib and trastuzumab...

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2oqEaK3
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Δημοφιλείς αναρτήσεις